Variable | HR (95% CI) | p-value |
---|---|---|
DTWD2 (protein) | 0.15 (0.032–0.69) | 0.014 |
LGALS3 (protein) | 2.6 (1.2–5.5) | 0.015 |
ALDH1A1 (gene) | 0.084 (0.01–0.68) | 0.02 |
NSDHL (protein) | 0.63 (0.42–0.94) | 0.026 |
BLMH (protein) | 1.6 (1–2.5) | 0.03 |
ALDH1A1 (protein) | 0.39 (0.16–0.91) | 0.03 |
Age | 0.85 (0.74–0.98) | 0.03 |
LGALS3BP (gene) | 7.1 (1.2–43) | 0.032 |
LGALS3BP (protein) | 2.6 (1.1–6.1) | 0.036 |
LGALS3 (gene) | 2.9 (1–8.3) | 0.05 |
HAL (protein) | 1.4 (1–2.1) | 0.05 |
RETREAT score | 2 (0.94–4.3) | 0.074 |
THBS1 (protein) | 1.5 (0.96–2.4) | 0.077 |
DTWD2 (gene) | 0.17 (0.023–1.2) | 0.08 |
GSTA2 (gene) | 0.72 (0.49–1) | 0.081 |
MGST1 (protein) | 0.67 (0.42–1.1) | 0.094 |
HAL (gene) | 1.9 (0.88–4.2) | 0.1 |
BLMH (gene) | 2.3 (0.85–6) | 0.1 |
NQO2 (protein) | 0.57 (0.29–1.1) | 0.11 |
NQO2 (gene) | 0.44 (0.15–1.3) | 0.14 |
NSDHL (gene) | 0.045 (0.00051–3.9) | 0.17 |
THBS1 (gene) | 1.7 (0.79–3.5) | 0.18 |
GSTA2 (protein) | 0.83 (0.62–1.1) | 0.19 |
AFP | 1 (1–1) | 0.23 |
MGST1 (gene) | 0.55 (0.2–1.5) | 0.24 |
microvascular invasion | 2.2 (0.45–10) | 0.33 |
No. of tumors | 1.1 (0.93–1.2) | 0.42 |